A skin sample might aid physicians in diagnosing patients with familial amyloid polyneuropathy (FAP) caused by mutations in the TTR gene, according to a study…
News
HATTR-PN
NewsInotersen Seen to Improve Neurological Symptoms, Quality of Life of FAP Patients in Phase 3 Trial
The investigative drug inotersen was shown to significantly reduce neurological progression and improve quality of life in patients with familial amyloid polyneuropathy (FAP) – also…
HATTR-PN
NewsDNA Mutation May Play a Role in Age at Which Familial Amyloid Polyneuropathy Starts, Study Reports
The age at which symptoms of familial amyloid polyneuropathy (FAP) start showing up…
Recent Posts
- Advocates aim to raise awareness on World Amyloidosis Day
- Most ATTR patients in China have symptoms of 2 amyloidosis types
- Improving how public transportation treats people with special needs
- Lower hospitalization risk seen with one ATTR-CM treatment in real-world study
- World Amyloidosis Day isn’t just about advocacy; it’s also a celebration